Pathogenesis of duodenal ulcer disease: The rest of the story

Bailliere's Best Practice and Research in Clinical Gastroenterology

Volumn 14, Issue 1, 2000, Pages 97-107

  Dore, Maria P ^a   Graham, David Y ^a  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Acid secretion; Duodenal acid load; H. pylori; Peptic ulcer disease

Indexed keywords

ANTACID AGENT; BILE SALT; GASTRIN; STOMACH SECRETION INHIBITOR;

BACTERIAL GROWTH; DUODENITIS; DUODENUM ULCER; ERADICATION THERAPY; GASTRIN RELEASE; GASTRITIS; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; INTESTINE METAPLASIA; PATHOGENICITY; REVIEW; STOMACH ACID SECRETION; STOMACH PARIETAL CELL; ULCEROGENESIS;

EID: 0034059678     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1053/bega.1999.0061     Document Type: Article

References (62)

1. Graham D Y, Go M F. Helicobacter pylori: current status. Gastroenterology. 105:1993;279-282.
2. Soll A H. Pathogenesis of peptic ulcer and implications for therapy. New England Journal of Medicine. 322:1990;909-916.
3. Soll A H, Weinstein W M, Kurata J. Nonsteroidal anti-inflammatory drugs and peptic ulcer disease. Annals of Internal Medicine. 114:1991;307-319.
4. Sachs G, Prinz C K, Hersey S J. Acid-related Disorders: Mystery to Mechanism, Mechanism to Management. 1995;Sushu Publishing, Palm Beach.
5. Soll A H. Gastric, duodenal, and stress ulcer. Sleisenger M, Fordtran J. Gastrointestinal Disease. 1993;580-679 WB Saunders, Philadelphia.
6. Graham D Y. Campylobacter pylori and peptic ulcer disease. Gastroenterology. 96:1989;615-625.
7. Faber K. Chronic gastritis: its relation to achylia and ulcer. Lancet. 901:1927;902-907.
8. Ota H, Genta R M. Morphological characterization of the gastric mucosa during infection with H. pylori. Ernst P, Michetti P, Smith P D. The Immunobiology of H. pylori from Pathogenesis to Prevention. 1997;15-28 Lippincott-Raven, Philadelphia.
9. Dixon M F. Helicobacter pylori and peptic ulceration: histopathological aspects. Journal of Gastroenterology and Hepatology. 6:1991;125-130.
10. Kekki M, Villako K, Tamm A. Dynamics of antral and fungal gastritis in an Estonian rural population sample. Scandinavian Journal of Gastroenterology. 12:1977;321-324.
11. Tarpila S, Kekki M, Samloff I M. Morphology and dynamics of the gastric mucosa in duodenal ulcer patients and their first-degree relatives. Hepato-gastroenterology. 30:1983;198-201.
12. Kekki M, Saukkonen M, Sipponem P. Dynamics of chronic gastritis in the remnant after partial gastroectomy for duodenal ulcer. Scandinavian Journal of Gastroenterology. 15:1980;509-512.
13. Kuipers E J, Lee A, Klinkenberg-Knol E C. The development of atrophic gastritis - Helicobacter pylori and the effects of acid suppressive therapy. Alimentary Pharmacology and Therapy. 9:1995;331-340.
14. Meining A, Keil G, Stolte M. Changes in Helicobacter pylori -induced gastritis in the antrum and corpus under 12 months of treatment with ranitidine and lansoprazole in patients with duodenal ulcer disease. Gastroenterology. 114:1998;224.
15. Graham D Y. Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: a model. Gastroenterology. 113:1997;1983-1991.
16. Graham D Y, Yamaoka Y. H. pylori and cagA: relationships with gastric cancer, duodenal ulcer, and reflux esophagitis and its complications. Helicobacter. 3:1998;145-151.
17. Steer H W. Ultrastructure of cell migration through the gastric epithelium and its relationship to bacteria. Journal of Clinical Pathology. 28:1975;639-646.
18. Steer H W, Colin-Jones D G. Mucosal changes in gastric ulceration and their response to carbenoxolone sodium. Gut. 16:1975;590-597.
19. Steer H W. Surface morphology of the gastroduodenal mucosa in duodenal ulceration. Gut. 25:1984;1203-1210.
20. Marshall B H, Warren J R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1:1984;1311-1315.
21. Marshall B J, Armstrong J A, McGechie D B. Attempt to fulfil Koch's postulates for pyloric Campylobacter. Medical Journal of Australia. 42:1985;436-439.
22. Morris A, Nicholson G. Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH. American Journal of Gastroenterology. 82:1987;192-199.
23. McNulty C A, Gearty J C, Crump B. Campylobacter pyloridis and associated gastritis: investigator blind, placebo controlled trial of bismuth salicylate and erythromycin ethylsuccinate. British Medical Journal. 293:1986;645-649.
24. Rohrer G V, Welsh J D. Correlative study: gastric secretion and histology. Gastroenterology. 52:1967;185-191.
25. Funder F F, Weiden S. The correlation between test-meal findings and histology of the stomach as shown by gastric biopsy. Medical Journal of Australia. 1:1952;600-602.
26. McGuigan J E, Trudeau W L. Differences in rates of gastrin release in normal persons and patients with duodenal-ulcer disease. New England Journal of Medicine. 288:1973;64-66.
27. Graham D Y, Hepps K S, Ramirez F C. Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease. Scandinavian Journal of Gastroenterology. 28:1993;939-942.
28. Peterson W L, Barnett C C, Evans D J Jr. Acid secretion and serum gastrin in normal subjects and patients with duodenal ulcer: the role of Helicobacter pylori. American Journal of Gastroenterology. 88:1993;2038-2043.
29. Graham D Y. Helicobacter pylori: its epidemiology and its role in duodenal ulcer disease. Journal of Gastroenterology and Hepatology. 6:1991;105-113.
30. McColl K E, Fullarton G M, Chittajalu R. Plasma gastrin, daytime intragastric pH, and nocturnal acid output before and at 1 and 7 months after eradication ofHelicobacter pylori in duodenal ulcer subjects. Scandinavian Journal of Gastroenterology. 26:1991;339-346.
31. Calam J. Helicobacter pylori, acid and gastrin. European Journal of Gastroenterology and Hepatology. 7:1995;310-317.
32. el-Omar E M, Penman I D, Ardill J E. Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology. 109:1995;681-691.
33. Hirschowitz B I, Tim L O, Helman C A. Bombesin and G-17 dose responses in duodenal ulcer and controls. Digestive Diseases and Sciences. 30:1985;1092-1103.
34. el-Omar E, Penman I, Dorrian C A. Eradicating Helicobacter pylori infection lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcer. Gut. 34:1993;1060-1065.
35. el-Omar E, Penman I, Ardill J E. A substantial proportion of non-ulcer dyspepsia patients have the same abnormality of acid secretion as duodenal ulcer patients. Gut. 36:1995;534-538.
36. Graham D Y. Helicobacter pylori and perturbations in acid secretion: the end of the beginning. Gastroenterology. 110:1996;1647-1650.
37. Graham D Y, Dore M P. Perturbations in gastric physiology in Helicobacter pylori duodenal ulcer: are they all epiphenomena? Helicobacter. 1:1997;S44-S49.
38. Blair A J III, Feldman M, Barnett C. Detailed comparison of basal and food-stimulated gastric acid secretion rates and serum gastrin concentrations in duodenal ulcer patients and normal subjects. Journal of Clinical Investigation. 79:1987;582-587.
39. Moss S, Calam J. Helicobacter pylori and peptic ulcers: the present position. Gut. 33:1992;289-292.
40. Malagelada J R, Longstreth G F, Deering T B. Gastric secretion and emptying after ordinary meals in duodenal ulcer. Gastroenterology. 73:1977;989-994.
41. Olbe L, Hamlet A, Dalenback J. A mechanism by which Helicobacter pylori infection of the antrum contributes to the development of duodenal ulcer. Gastroenterology. 110:1996;1386-1394.
42. Walsh J H, Richardson C T, Fordtran J S. pH dependence of acid secretion and gastrin release in normal and ulcer subjects. Journal of Clinical Investigation. 55:1975;462-468.
43. Sjovall M, Lindstedt G, Olbe L. Defective inhibition of gastrin release by antral distension in duodenal ulcer patients. Digestion. 51:1992;1-9.
44. Kihl B, Olbe L. Inhibition of pentagastrin-stimulated gastric acid secretion by graded intraduodenal administration of oleic acid in man. Scandinavian Journal of Gastroenterology. 16:1981;121-128.
45. Schwarz K. Ueber penetrierende magen and jejunalgeschwere. Beitrage Fur Klinischen Chirurgie. 67:1910;96-128.
46. Moss S F, Calam J. Acid secretion and sensitivity to gastrin in patients with duodenal ulcer: effect of eradication of Helicobacter pylori. Gut. 34:1993;888-892.
47. Parente F, Maconi G, Sangaletti O. Behaviour of acid secretion, gastrin release, serum pepsinogen I, and gastric emptying of liquids over six months from eradication of Helicobacter pylori in duodenal ulcer patients. A controlled study. Gut. 37:1995;210-215.
48. Malaty H M, Graham D Y, Isaksson I. Are genetic influences on peptic ulcer dependent or independent of genetic influences for H. pylori infection? Archives of Internal Medicine. 1999.
49. Graham D Y, Evans D G, Evans D J Jr. Campylobacter pylori. The organism and its clinical relevance. Journal of Clinical Gastroenterology. 11:1989;S43-S48.
50. Tatsuta M, Iishi H, Yamamura H. Enhancement by tetragastrin of experimental induction of gastric epithelium in the duodenum. Gut. 30:1989;311-315.
51. Parrish J A, Rawlins D C. Intestinal mucosa in the Zollinger-Ellison syndrome. Gut. 6:1965;286-289.
52. Rhodes J, Evans K T, Lawrie J H. Coarse mucosal folds in the duodenum. Quarterly Journal of Medicine. 37:1968;151-169.
53. Solcia E, Villani L, Fiocca R. Effects of eradication of Helicobacter pylori on gastritis in duodenal ulcer patients. Scandinavian Journal of Gastroenterology. 201:1994;28-34.
54. Wyatt J I, Rathbone B J, Dixon M F. Campylobacter pyloridis and acid induced gastric metaplasia in the pathogenesis of duodenitis. Journal of Clinical Pathology. 40:1987;841-848.
55. Marshall B J, Royce H, Annear D I. Original isolation of Campylobacter pyloridis from human gastric mucosa. Microbios Letters. 1984;83-88.
56. Han S W, Evans D G, el-Zaatari F A. The interaction of pH, bile, and Helicobacter pylori may explain duodenal ulcer. American Journal of Gastroenterology. 91:1996;1135-1137.
57. Borody T J, George L L, Brandl S. Smoking does not contribute to duodenal ulcer relapse after Helicobacter pylori eradication. American Journal of Gastroenterology. 87:1992;1390-1393.
58. Graham D Y, Lew G M, Klein P D. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Annals of Internal Medicine. 116:1992;705-708.
59. Graham D Y, Gutierrez O, Angle A. Role of interleukin-1 (IL-1) in the inhibition of acid secretin in Helicobacter pylori corpus gastritis in humans. Gastroenterology. 116:1999;A176.
60. Hobsley M, Whitfield P F, Faber R G. Hypersecretion and length of history in duodenal ulceration. Lancet. 2:1975;101-104.
61. Graham D Y, Opekun A R, Osato M. Challenge model for H. pylori infection in human volunteers. Gastroenterology. 116:1999;A176.
62. Hamlet A, Thoreson A C, Nilsson O. Duodenal Helicobacter pylori infection differs in cagA genotype between asymptomatic subjects and patients with duodenal ulcers. Gastroenterology. 116:1999;259-268.